Article Information
- Received April 9, 2018
- Revision received May 15, 2018
- Accepted May 16, 2018
- Published online June 15, 2018.
Author Information
- 1Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030
- Correspondence should be addressed to Melina A. Agosto, Department of Biochemistry and Molecular Biology, BCM-125, Baylor College of Medicine, 1 Baylor, Plaza, Houston, TX 77030, E-mail: agosto{at}bcm.edu.
Author contributions
Author contributions: M.A.A., I.A.A., and T.G.W. designed research; M.A.A., I.A.A., and M.A.R. performed research; M.A.A., I.A.A., M.A.R., and T.G.W. analyzed data; M.A.A., I.A.A., M.A.R., and T.G.W. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by National Institutes of Health (NIH) Grants R01-EY007981/EY007981-S1, R01-EY025218, and R01-EY026545 (to T.G.W.), F32-EY020067 (to M.A.A.), F32-EY024815 (to I.A.A.), and F32-EY027171 (to M.A.R.); by a Knights Templar Eye Foundation Pediatric Ophthalmology Career-Starter Grant (to M.A.A.); by the Welch Foundation Grant Q0035; and by the Monoclonal Antibody/Recombinant Protein Expression Shared Resource at Baylor College of Medicine with funding from NIH Cancer Center Support Grant P30-CA125123.
Funding
HHS | NIH | National Eye Institute (NEI)
R01-EY007981; R01-EY025218; R01-EY026545; F32-EY020067; F32-EY024815; F32-EY027171Knights Templar Eye Foundation (KTEF)
Welch Foundation
Q0035HHS | NIH | National Cancer Institute (NCI)
P30 CA125123
Other Version
- You are viewing the most recent version of this article.
- previous version (June 15, 2018).
Online Impact